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ABSTRACT: Our aim was to contribute to a better understanding of the pathophysiology of anemia in 
elderly, by studying how aging affects renal function, iron metabolism, erythropoiesis and the 
inflammatory response, using an experimental animal model. The study was performed in male Wistar, a 
group of young rats with 2 months age and an old one with 18 months age. Old rats presented a significant 
higher urea, creatinine, interferon (INF)-gamma, ferritin and soluble transferrin receptor serum levels, as 
well as increased counts of reticulocytes and RDW. In addition, these rats showed significant lower 
erythropoietin (EPO) and iron serum levels. Concerning gene expression of iron regulatory proteins, old 
rats presented significantly higher mRNA levels of hepcidin (Hamp), transferrin (TF), transferrin receptor 
2 (TfR2) and hemojuvelin (HJV); divalent metal transporter 1 (DMT1) mRNA levels were significantly 
higher in duodenal tissue; EPO gene expression was significantly higher in liver and lower in kidney, and 
the expression of the EPOR was significantly higher in both liver and kidney. Our results showed that aging 
is associated with impaired renal function, which could be in turn related with the inflammatory process 
and with a decline in EPO renal production. Moreover, we also propose that aging may be associated with 
INF-gamma-induced inflammation and with alterations upon iron regulatory proteins gene expression. 
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Epidemiological studies show an increased occurrence of 
anemia with aging, with a prevalence of about 5% at 65 
years, to more than 20% at the age of 85 years [1,2]. 
Previous studies showed that anemia, per se, is 
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associated with higher morbidity, risk of hospitalization, 
and mortality rates [2,3]. When the identifiable causes of 
anemia are excluded, such as erythropoietic nutrient 
deficiencies, inflammatory conditions and chronic 
kidney disease (CKD), the prevalence of anemia is still 
high in the elderly population. In fact, several studies 
showed that as much as 1/3 of the anemia in older 
population is of unexplained cause [4-6].  Some possible 
explanations for the increased prevalence of anemia of 
unknown etiology in advancing age have been suggested 
[7-10]. Indeed, aging is characterized by a progressive 
mild pro-inflammatory status, as shown by the rising 
levels of pro-inflammatory markers [11]. This 
phenomenon can be partially explained by the increasing 
prevalence of chronic diseases; however, even when 
healthy older individuals were studied, they still had 
higher levels of pro-inflammatory cytokines and acute 
phase reactive proteins [11-14]. Additionally, a positive 
association between inflammation and erythropoietin 
(EPO) serum levels has been reported in old individuals 
without anemia [13]. These findings suggest that 
inflammation might hamper the response to EPO. 
Furthermore, it is known that increased levels of 
hepcidin (Hamp) are involved in the pathogenesis of the 
anemia of inflammation [10,11]. Nevertheless, it is still 
unclear whether the mild-pro-inflammatory state 
associated with aging, causes Hamp up-regulation and 
contributes to the development of anemia. More recently, 
it was reported that the anemia of chronic diseases is 
dependent on interferon-γ and that this cytokine reduces 
both the life span and the production of red blood cells 
[14]. This effect upon red blood cells has been attributed 
to interferon-γ capacity of inducing the expression of 
transcription factors of interferon regulatory factor-1 and 
PU.1 in human erythroid precursors, leading to inhibition 
of erythropoiesis.  
Aging is also associated with physiological, 
functional and morphological changes in kidneys, which 
are similar to those found in CKD, though to a lesser 
extent [15]. Inflammation is also associated to aging-
related diseases, and to progression of CKD [16]. The 
kidney is the major local of EPO synthesis, and one of 
the mechanisms proposed for the pathogenesis of the 
unexplained anemia in older people is an inadequate 
EPO production. In fact, it has been suggested that the 
ability of kidneys to secrete EPO in response to tissue 
hypoxia declines with aging. However, EPO levels in 
non-anemic older persons are conflicting, as some 
studies showed higher EPO levels, and other studies do 
not confirm that finding [17].  
The aim of this work was therefore to contribute to a 
better understanding of the pathophysiology of anemia in 
elderly, by studying how aging affects renal function, 
iron metabolism and the inflammatory response, using 
for that purpose an experimental animal model; old male 
Wistar rats, aged 18 moths, were compared to young  
male Wistar rats, aged 2 months. The determinations 
included analytical blood studies (basic hematological 
study, reticulocyte count, glucose, urea and creatinine 
levels, C-reactive protein, interleukin-6, interferon-γ, 
iron, ferritin, transferrin, soluble transferrin receptor and 
erythropoietin concentrations) kidney histopathological 
studies and gene expression analysis of transferrin 
receptor 2 (TfR2), hepcidin (Hamp), ferroportin 
(SLC40A1), hemojuvelin (HJV), transferrin (TF), 
hemochromatosis (Hfe) in liver tissue; divalent metal 
transporter 1 (DMT1) gene expression in duodenal 
tissue, as well EPO and EPO receptor (EPOR) gene 
expression in both liver and kidney. 
 
MATERIAL AND METHODS 
 
Animals and groups 
 
Two groups of male Wistar rats (Charles River Lab. Inc., 
Barcelona, Spain) were evaluated in this study: one of 
young rats, with only 2 months of age (n=8) and the 
other of natural aging rats, with 18 months of age (n=7). 
The rats were maintained in an air-conditioned room, 
subjected to 12 h dark/light cycles and given standard 
laboratory rat diet (IPM-R20, Letica, Barcelona, Spain) 
and free access to tap water. Animal experiments were 
conducted according to the European Communities 
Council Directives on Animal Care and to the National 
Authorities, and the study received approval from the 
Institutional Ethics Committee of the Faculty of 
Medicine from the University of Coimbra. Approval ID: 
FMUC/10/11. 
 During the entire experimental protocol, the body 
weight and the amount of beverage consumption were 
monitored.  
 
Blood and tissue collection 
 
At the end of the experimental protocol the rats were 
submitted to intraperitoneal anesthesia with 2.0 mg/kg of 
a 2:1 (v:v) 50.0 mg/mL ketamine (Ketalar®, Parke-
Davis, Pfizer Laboratories Lda, Seixal, Portugal) 
solution in 2.5% chlorpromazine (Largatil®, Rhône-
Poulenc Rorer, Vitória Laboratories, Amadora, 
Portugal). Blood samples were immediately collected by 
venepuncture from the jugular vein into vacutainer tubes 
with anticoagulant (EDTA) and without anticoagulant, in 
order to obtain whole blood, plasma and serum. Under 
anesthesia the rats were sacrificed by cervical 
dislocation, and the liver, heart, kidneys and duodenum 
were immediately removed, weighed and placed in ice-
cold Krebs buffer; the organs were carefully cleaned 
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from adherent fat and connective tissue. Two small 
portions of the liver, kidney and duodenum from each rat 
were prepared for histopathological analysis (further 
placed in formaldehyde) and for the genetic studies; to 
isolate total RNA, 0.2 g samples of liver, duodenum and 
kidney, from each rat, were immersed in RNA laterTM 
(Ambion, Austin, USA) and stored at 4 °C for 24h; 
afterwards, samples were frozen at -80oC. The body 
weight (BW) and the weight of kidneys (KW), heart 
weight (HW) and left ventricle weight (LVW) were used 
to calculate the tropism indexes (KW/BW, HW/BW, 
LVW/HW and LVW/BW). 
 
 
 
Table 1. Body and tissue weight, trophism indexes, hematological, biochemical and 
inflammatory data, iron metabolism and EPO levels in young and old rats 
 
 
*p<0.05 vs. young rats; **p=0.056 vs. young rats; ***p=0.065 vs. young rats; results are presented as mean ± s.e.m.  
BW: body weight; HW: heart weight; LVW: left ventricle weight; KW: Kidney weight; RBC: red blood cell; MCV: 
mean cell volume; MCH: mean cell hemoglobin; MCHC: mean cell hemoglobin concentration; RDW: red blood cell 
distribution width; hsCRP: high sensitive C-reactive protein; IL-6: interleukin-6; INF-: interferon-gamma; sTfR: 
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soluble transferrin receptor; EPO: erythropoietin.  
 
 
Hematological data 
 
Erythrocyte, leukocyte and platelet counts, hematocrit, 
hemoglobin concentration and hematimetric indices 
[mean cell volume (MCV), mean cell hemoglobin 
(MCH) and mean cell hemoglobin concentration 
(MCHC)] were measured by using an automatic blood 
cell counter (Sysmex K1000; Sysmex, Hamburg, 
Germany). Reticulocyte count was performed by 
microscopic counting on blood smears after vital staining 
with new methylene blue (reticulocyte stain; Sigma, St. 
Louis, Mo., USA).  
 
Biochemical data 
 
Serum levels of creatinine, urea and glucose 
concentrations were analyzed on a Hitachi 717 analyzer 
(Roche Diagnostics Inc., Massachuasetts, USA) using 
standard methods.  
Serum iron concentration was determined using a 
colorimetric method (Iron, Randox Laboratories Ltd., 
North Ireland, UK), whereas serum ferritin and serum 
transferrin were measured by immunoturbidimetry 
(Ferritin, Laboratories Ltd., North Ireland, UK; 
Transferrin, Laboratories Ltd., North Ireland, UK). An 
enzyme-linked immunosorbent assay was used to 
measure plasma soluble transferrin receptors (s-TfR) 
(Human sTfR immunoassay, R&D systems, MN, USA). 
Serum levels of interleukin-6 (IL-6) and interferon-  
(IFN-), were measured by rat-specific Quantikine 
ELISA kits from R&D Systems (Minneapolis, USA). 
High-sensitive C-reactive protein (hsCRP) was 
determined by using a rat-specific Elisa kit from Alpha 
Diagnostic International (San Antonio, USA). Serum 
erythropoietin (EPO) concentrations were measured by 
rat ELISA kit (Eiaab Science Co. Ltd, Wuban, China). 
All assays were performed according to the 
manufacturers’ recommendations, in duplicate. 
 
Kidney histopathological analysis 
 
Renal tissue samples were fixed in Bock's fixative and 
embedded in paraffin wax; afterwards, 4 μm thick 
sections were stained with hematoxylin and eosin (HE) 
for routine histopathological analysis.  
To quantify renal lesions we also performed a 
Periodic Acid of Schiff (PAS) staining. Renal tissue 
samples were fixed in 10% neutral formalin and 
embedded in paraffin wax; tissue sections, 4 μm thick, 
were prepared and mounted on slides that were 
immersed in water and subsequently treated with an 
aqueous solution of periodic acid (1%); slides were 
washed to remove any traces of the periodic acid, and, 
finally, were treated with Schiff's reagent. All samples 
were examined by light microscopy using a Microscope 
Zeiss Mod. Axioplan 2. The degree of injury was scored 
in a double-blinded fashion by two independent 
pathologists. Lesions were evaluated on the total tissue 
on the slide. 
Glomerular damage was assessed by evaluating 
mesangial expansion, glomerular basement membrane 
and capsule of Bowman thickening, nodular sclerosis, 
glomerulosclerosis, atrophy, and hyalinosis of the 
vascular pole. Tubulointerstitial lesions were assessed by 
inflammatory infiltration, presence of hyaline cylinders, 
tubular basement membrane irregularity, tubular 
calcification, and by the association of interstitial fibrosis 
and tubular atrophy (IFTA). The evaluation of vascular 
lesions was concentrated on arteriolar hyalinosis, 
arteriolosclerosis and arteriosclerosis. A semi-
quantitative rating for each slide, ranging from normal 
(or minimal) to severe (extensive damage), was assigned 
to each component. Severity was graded as 
absent/normal (0), mild (1), moderate (2), and severe (3). 
Scoring was defined according to the extension occupied 
by the lesion (number of capsules): normal: 0%; mild: 
<25%; moderate: 25–50%; severe: >50%. The final 
score for each sample was obtained by the average 
scores observed in individual glomeruli in the considered 
microscopic fields. Tubular calcification was evaluated 
and graded by the same semiquantitative method. 
Regarding vascular lesions, arteriosclerosis was scored 
as 0 if no intimal thickening was present, as 1 if intimal 
thickening was less than the thickness of the media, and 
as 2 if intimal thickening was more than the thickness of 
the media and considering the worst artery on the slide. 
Using PAS, the rating was set for intensity and extension 
of staining, ranging from 0 (no staining) to 3 (intense and 
extensive staining), respecting tissue specificity scoring 
when adequate. 
 
Gene expression analysis 
 
Tissue samples (50±10 mg) immersed in RNA laterTM 
were homogenized in 1 ml TRI® Reagent (Sigma, 
Sintra, Portugal), using a homogenizer, and total RNA 
was isolated as described in the TRI® Reagent Kit. To 
ensure inactivation of contaminating RNAses, metal 
objects and glassware were cleaned with detergent, 
immersed in RNAse-free water (0.2% diethyl 
pyrocarbonate) for 2 h and, finally, heated at 120oC for 1 
h. RNA integrity (RIN, RNA Integrity Number) was 
analyzed using 6000 Nano ChipW kit, in Agilent 2100 
bioanalyzer (Agilent Technologies, Walbronn, Germany) 
 E. Costa et al                                                                                                             Aging and erythropoietic disturbances 
Aging and Disease • Volume 5, Number 2, April 2014                                                                                 5 
 
and 2100 expert software, following manufacturer 
instructions. The yield from isolation ranged from 0.5 to 
1.5 μg; RIN values were 7.0–9.0 and purity 
(A260/A280) was 1.8–2.0. The concentration of the 
RNA preparations were confirmed with NanoDrop1000 
(ThermoScientific, Wilmington, DE, USA). Possible 
contaminating remnants of genomic DNA were 
eliminated by treating these preparations with 
deoxyribonuclease I (amplication grade) prior to RT-
qPCR amplification. Reverse transcription and relative 
quantification of gene expression were performed as 
previously described [18]. Real-time qPCR reactions 
were performed using the following primer sequences 
for EPO, EPOR, Transferrin receptor 2 (TfR2), Hepcidin 
(Hamp), Ferroportin (SLC40A1), Hemojuvelin (HJV), 
Transferrin (TF), Hemochromatosis (Hfe) and Divalent 
Metal Transporter 1 (DMT1), which were normalized in 
relation to the expression of beta-actin (Actb), and 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 
EPO Forward: AGG GTC ACG AAG CCA TGA AG, 
EPO Reverse: GAT TTC GGC TGT TGC CAG TG; 
EPOR Forward: GCG ACT TGG ACC CTC TCA TC, 
EPOR Reverse: AGT TAC CCT TGT GGG TGG TG; 
TfR2 Forward: CAA GCT TCG CCC AGA AGG TA, 
TfR2 Reverse: CGT GTA AGG GTC CCC AGT TC; 
Hamp Forward: GAA GGC AAG ATG GCA CTA 
AGC, Hamp Reverse: CAG AGC CGT AGT CTG TCT 
CG; SLC40A1 Forward: CAG GCT TAG GGT CTA 
CTG CG , SLC40A1 Reverse: CCG AAA GAC CCC 
AAA GGA CA; HJV Forward: GCC TAC TTC CAA 
TCC TGC GT, HJV Reverse: GGT CAA GAA GAC 
TCG GGC AT; TF Forward: GGC ATC AGA CTC 
CAG CAT CA, TF Reverse: GCA GGC CCA TAG 
GGA TGT T; Hfe Forward: CTG GAT CAG CCT CTC 
ACT GC, Hfe Reverse: GTC ACC CAT GGT TCC TCC 
TG; DMT1 Forward: CAA CTC TAC CCT GGC TGT 
GG, DMT1 Reverse: GTC ATG GTG GAG CTC TGT 
CC; GAPDH Forward: CCA CTA AAG GGC ATC 
CTG GG, GAPDH Reverse: CAT TGA GAG CAA TGC 
CAG CC; Actb Forward: GAG ATT ACT GCC CTG 
GCT CC, Actb Reverse: CGG ACT CAT CGT ACT 
CCT GC. Results were analyzed with SDS 2.1 software 
(Applied Biosystems, Foster City, CA, USA) and the 
relative quantification was calculated by using the 
2ΔΔCt method [19]. 
 
Table 2.  Scoring and distribution of glomerular and tubular lesions in the groups under study at the final time 
 
 
 
Data analysis 
 
For statistical analysis, we used the Statistical Package 
for Social Sciences (SPSS), version 19.0. Results are 
presented as mean ± s.e.m. Comparisons between groups 
were performed using Mann-Whitney U test. 
Significance was accepted at p less than 0.05. 
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Figure 1.  Transferrin receptor 2 (TfR2), hepcidin (Hamp), ferroportin (SLC40A1), hemojuvelin (HJV), 
transferrin (TF), hemochromatosis (Hfe) gene expression in liver tissue for both groups of rats (young and old). 
 
 
 
 
RESULTS 
 
The results were analyzed by comparing the two groups 
under study – young and old rat groups. The old rats 
presented a significant higher BW, in HW and KW, 
when compared with young rats. However, a significant 
decrease in all tissue trophy indexes was found for old 
rats group (table I).  
The hematological study showed a trend towards a 
lower erythrocyte count, hematocrit and hemoglobin 
concentration in old rats, which was associated with a 
significant higher RDW and lower reticulocyte count, 
that almost achieved statistical significance (p= 0.065). 
A significant higher urea and creatinine serum levels was 
also found in old rats. Moreover, higher levels of INF-, 
ferritin and transferrin, as well as a significant decrease 
in EPO and lower iron serum levels were seen for old 
rats (table I).  
Iron regulatory proteins gene expression, in liver 
tissue of old rats, showed a significant higher Hamp, TF, 
TfR2, and HJV expression; a trend towards a higher gene 
expression was also observed for SLC40A1 and HFE 
(Fig. 1). We also found in old rats duodenum, a higher 
DMT1 expression (Fig. 2). Additionally, EPO gene 
expression was also significantly up-regulated in liver, 
while down-regulated in kidney; expression of EPOR 
was significantly up-regulated in both liver and kidney 
tissues (Fig. 3). 
Concerning to kidney histomorphology (table II), we 
found that only old rats presented glomerular lesions 
(mild-to-moderate), namely thickening of CB (mild 
57.1%; moderate 14.3%), hyalinosis of vascular pole (in 
the entire group), dilatation of the Bowman s´ Space 
(mild: 28.6%) (Fig.4A), and hypercellularity (mild 
57.1%; moderate 14.3%); the entire group also presented 
mild to moderate tubular lesions (table II), such as IFTA, 
interstitial inflammatory infiltration, hyaline cylinders 
and vacuolar tubular degeneration. Regarding vascular 
lesions, old rats showed arteriosclerosis and 
arteriolosclerosis (Fig. 4B).  
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Figure 2. Divalent metal transporter 1 (DMT1) gene 
expression in duodenal tissues.  
 
 
DISCUSSION 
 
Most of the studies performed to clarify the 
pathophysiology of anemia of the elderly, were 
performed in old humans. The frequent association of 
comorbidities and polypharmacy to advanced age, turns 
very difficult the study of the etiology and 
pathophysiology of this particular anemia. However, it 
would be important to understand how biological 
changes occurring with aging, underlie the development 
of an unexplained anemia, as occurs in one third of 
elderly patients with anemia. To achieve this, it would be 
necessary to analyze the crosstalk between anemia, 
inflammation and iron metabolism, by performing 
diverse studies at blood, tissue and molecular levels, in 
old individuals. Since these types of studies are not 
ethical in healthy old humans, we performed them using 
a natural aged rat model. 
 
 
 
 
Figure 3. Erythropoietin (EPO) and erythropoietin receptor (EPOR) gene 
expression in liver (A and C) and kidney (B and D).  
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Figure 4. Renal histological changes associated with aging.  (A) Example of atherosclerotic grade 
1 lesions found in arteries of old rats (X40), intimal thickening (I) less than thickness of media (M).  
(B) Dilatation of the Bowman s´ Space (X20), N–normal glomerulus, BS – Bowman s´ Space. (C) 
Arteries of young rats without changes (X40). (D) Normal glomerulus.   
 
 
In this study, our model does not present yet anemia, 
since these rats are not very old. However, they 
presented already higher inflammatory markers and 
alterations in renal function and in iron metabolism, 
associated with mild erythropoietic disturbances. These 
data could be helpful to better understand the 
modifications that could lead to the development of 
anemia associated with aging. However, it seems 
important, in the future, to evaluate an older model (i.e. 
24 months) that might highlight the erythropoietic, renal 
and inflammatory changes already observed in this 
model with “just” 18 months of age.  
We found that our aged rat model has an impaired 
renal function, as shown by the significantly increased 
levels of urea and creatinine, associated with a 
significant decrease in its ability to secrete EPO; the 
kidney weight/body trophy index was significantly 
decreased and several histological changes in renal tissue 
were also observed. Indeed, concerning to glomerular 
lesions, the entire group showed mild hyalinosis of the 
vascular pole and the majority showed mild to moderate 
thickening of CB, dilation of the Bowman’s space and 
hypercellularity; in addition, all the old rats showed 
tubular lesions, presenting hyaline cylinders, TBM 
irregularity, IFTA, interstitial inflammatory 
inflammation and vacuolar tubular degeneration. None 
of the young rats presented such histological findings. 
  Age-related changes in renal structure and function 
are well documented in humans and in a wide range of 
animal species [15]. Actually, renal function has been 
proposed as one of the major predictors of longevity 
[20]. However, the etiology of renal function decline and 
structural changes with aging are poorly clarified and 
have been related with several factors, namely, with 
comorbidities associated to oxidative stress and 
inflammation. 
The ability of the kidney to secrete EPO in response 
to hypoxia seems to decline with aging, despite the 
controversial data [21-23]. In fact, one of the proposed 
mechanisms for the pathogenesis of the unexplained 
anemia in elderly is an inadequate EPO production.  
As already referred, we found that old rats present 
lower EPO levels and lower numbers of reticulocytes, 
associated to a slightly lower hemoglobin concentration, 
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which suggests a decreased eryhtropoietic stimuli and, 
therefore, a reduced reticulocyte production; in 
accordance, we found that EPO gene was down-
regulated in the kidneys; oppositely, we found an 
increased EPO expression in hepatic tissue, which may 
be the result of a compensatory mechanism to overcome 
the decrease in renal EPO production.   
Besides the hematopoietic effect of EPO, it is known 
that EPO has a pleiotropic action, which might include 
renal, cardiovascular and nervous systems 
protection/regeneration [18, 24]. It has been reported that 
EPO has different intracellular signaling pathways in the 
kidney tissue, such as the PI3K/Akt pathway, a signaling 
pathway crucial for cell survival. In the present work, we 
found that old rats have an increased EPOR expression 
in both liver and kidney tissues, which might be a 
response to diminished EPO serum levels, in order to 
maximize the protective/regenerative effect of 
circulating EPO.  
Several authors have previously proposed that the 
anemia of unexplained etiology in elderly could have an 
inflammatory component [4-6]. An underlying 
inflammatory process leads to increased Hamp levels, 
the pivotal iron-regulatory peptide. Hamp acts as a 
negative regulator of intestinal iron absorption and 
inhibits the release of iron to be used in hemoglobin 
synthesis, from macrophages and hepatocytes, through 
the degradation of ferroportin, localized at the membrane 
surface of enterocytes, hepatocytes and macrophages; 
Hamp seems to represent the molecular link between 
chronic inflammation, body iron status and anemia.  A 
high Hamp production occurs in inflammatory and 
infectious diseases, leading to the development of 
anemia, known as the anemia of inflammation.  
In our model, the aged rats presented a decrease in 
iron serum levels, accompanied by an increase in ferritin 
and transferrin serum levels. These results suggest that 
aging is associated with a disturbance in iron 
metabolism, decreasing its iron availability for 
erythropoiesis, in spite of the increased iron storage. It is 
well documented that the gene encoding Hamp 
synthesis, in the liver, is regulated mainly by 
inflammatory cytokines, namely by IL-6 [25,26]. The 
old rats, as compared to young ones, presented an 
increased expression of Hamp gene; however, it is still 
unclear whether chronic inflammation and especially the 
mild-pro-inflammatory state associated with aging, 
causes Hamp up-regulation and contributes to anemia of 
aging. Indeed, IL-6 serum levels were not significantly 
different between young and old rats, suggesting that the 
mechanism underlying the up-regulation of Hamp gene 
expression is not related with IL-6 activating pathway. In 
accordance, we found that old rats presented increased 
hepatic TF, TfR2 and HJV gene expressions, which, are 
known to up-regulate Hamp expression [26,27]. 
Moreover, old rats presented increased ferritin serum 
levels, which are known to up-regulate Hamp gene 
expression in the liver [27]. In addition, as referred 
previously, kidney EPO gene expression and EPO 
circulating levels were decreased, which are known to 
up-regulate the Hamp expression.  
INF- has been shown to have a direct suppressive 
effect on the formation of erythroid colonies in vitro 
[14]. However, the molecular mechanism by which INF-
 inhibits erythroid differentiation is still poorly clarified. 
Old rats presented a significant reduction in circulating 
reticulocytes, suggesting a reduction in erythropoiesis. 
Furthermore, sTfR are usually increased when iron is not 
available for erythroid cells, and decreased when 
erythropoiesis is reduced. The reduced mean value 
observed for sTfR in old rats seems to result, mainly, 
from a reduction in erythropoiesis process. 
We also found in our aged rats an increase in DMT1 
gene expression at duodenal level, probably, reflecting 
an attempt to increase duodenal iron absorption, to 
counteract the low iron serum levels.  
Our results show that aging is associated with 
impaired renal function, which might be related to the 
inflammatory process and sclerosing modifications 
found in the renal tissue. These structural and functional 
kidney changes could lead to a decline in EPO renal 
production, reducing the erythropoietic stimuli. 
Moreover, we also showed that aging is associated with 
INF-induced inflammation and with changes in iron 
regulatory protein gene expression, including an increase 
in Hamp expression that will further alter erythropoiesis, 
by reducing iron absorption and mobilization. The 
increased hepatic EPO expression could be the result of 
a compensatory mechanism to overcome the decrease in 
renal EPO production. The increased EPOR expression, 
in both liver and kidney, might represent a 
protection/regenerating mechanism to counteract tissue 
aging.  
In conclusion, the anemia of the elderly seems to 
result from the interplay between renal, inflammatory 
and erythropoietic disturbances. A better understanding 
of the pathophysiological mechanisms underlying this 
yet unexplained anemia will improve the possibility to 
develop therapeutics strategies directed to this condition, 
in order to reduce the high healthy and socioeconomic 
cost associated with the disease. 
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